CoChat

Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder

Gris, Jean-Christophe, Mercier, Eric, Quéré, Isabelle, Lavigne-Lissalde, Géraldine, Cochery-Nouvellon, Eva, Hoffet, Médéric, Ripart-Neveu, Sylvie, Tailland, Marie-Laure, Dauzat, Michel, Marès, Pierre · 2004 · Blood

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Abstract

The prospective evaluation of the effect of thromboprophylaxis in women with one unexplained pregnancy loss from the 10th week of amenorrhea was performed. A total of 160 patients with heterozygous factor V Leiden mutation, prothrombin G20210A mutation, or protein S deficiency were given 5 mg folic acid daily before conception, to be continued during pregnancy, and low-dose aspirin 100 mg daily or low-molecular-weight heparin enoxaparin 40 mg was taken from the 8th week. Twenty-three of the 80 patients treated with low-dose aspirin and 69 of the 80 patients treated with enoxaparin had a healthy live birth (odds ratio [OR], 15.5; 95% confidence interval [CI], 7-34, P < .0001). Enoxaparin was superior to low-dose aspirin in each subgroup defined according to the underlying constitutional thrombophilic disorder. An associated protein Z deficiency and/or positive antiprotein Z antibodies were associated with poorer outcomes. The neonate weight was higher in the women successfully treated with enoxaparin, and neonates small for gestational age were more frequent in patients treated with low-dose aspirin. No significant side effects of the treatments could be evidenced in patients or newborns. As there is no argument to prove that low-dose aspirin may have been deleterious, these results support enoxaparin use during such at-risk pregnancies.

Overview

Integrity signals

Registry

Crossref · 10.1182/blood-2003-12-4250

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 26 references

Cited by

See all 397

Metadata

Authors
Gris, J.-C., Mercier, E., Quéré, I., Lavigne-Lissalde, G., Cochery-Nouvellon, E., Hoffet, M., Ripart-Neveu, S., Tailland, M.-L., Dauzat, M., & Marès, P.
Affiliations
  • Centre Hospitalier Universitaire de Nîmes (FR)
  • From the Hematology Laboratory, University Hospital, Nîmes, France; the Department of Gynecology and Obstetrics, University Hospital, Nîmes, France; the Hematology Laboratory, Montpellier 1 University, Montpellier; France; and the Equipe d'Accueil 2992, Montpellier 1 University, Montpellier; France.
Venue
Blood
Published
2004-05-15
Volume
103
Issue
10
Pages
3695-3699
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2036030218
Cited by
397
References
25
Citations by year
2026: 3 · 2025: 5 · 2024: 4 · 2023: 6 · 2022: 5 · 2021: 8 · 2020: 3 · 2019: 6 · 2018: 8 · 2017: 18 · 2016: 15 · 2015: 16 · 2014: 25 · 2013: 18 · 2012: 18
FWCI
27.19
Type
journal article
Language
en
Open access
closed
Locations
  • Blood (publishedVersion)
  • PubMed (publishedVersion)
Funders
Sanofi
Topics
  • Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
  • Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
  • Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
Keywords
low molecular weight heparin, enoxaparin, low-dose aspirin, thromboprophylaxis, recurrent pregnancy loss, thrombophilia, factor V Leiden, prothrombin G20210A, protein S deficiency, protein Z deficiency, folic acid supplementation, live birth rate, birth weight, small for gestational age
MeSH terms
Aspirin, Birth Weight, Female, Fetal Death, Folic Acid, Heparin, Low-Molecular-Weight, Humans, Pregnancy, Pregnancy Complications, Cardiovascular, Pregnancy Outcome, Odds Ratio, Enoxaparin, Thrombophilia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. https://app.cochat.ai/papers/10.1182/blood-2003-12-4250
The paper
Gris, J.-C., Mercier, E., Quéré, I., Lavigne-Lissalde, G., Cochery-Nouvellon, E., Hoffet, M., Ripart-Neveu, S., Tailland, M.-L., Dauzat, M., & Marès, P. (2004). Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood. https://doi.org/10.1182/blood-2003-12-4250

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.